These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20207017)

  • 1. Inhibition of C5a receptor alleviates experimental CNS lupus.
    Jacob A; Hack B; Bai T; Brorson JR; Quigg RJ; Alexander JJ
    J Neuroimmunol; 2010 Apr; 221(1-2):46-52. PubMed ID: 20207017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a alters blood-brain barrier integrity in experimental lupus.
    Jacob A; Hack B; Chiang E; Garcia JG; Quigg RJ; Alexander JJ
    FASEB J; 2010 Jun; 24(6):1682-8. PubMed ID: 20065106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus.
    Mahajan SD; Tutino VM; Redae Y; Meng H; Siddiqui A; Woodruff TM; Jarvis JN; Hennon T; Schwartz S; Quigg RJ; Alexander JJ
    Immunology; 2016 Aug; 148(4):407-19. PubMed ID: 27213693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
    Bao L; Osawe I; Puri T; Lambris JD; Haas M; Quigg RJ
    Eur J Immunol; 2005 Aug; 35(8):2496-506. PubMed ID: 16052609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of functional alternative complement pathway alleviates lupus cerebritis.
    Alexander JJ; Jacob A; Vezina P; Sekine H; Gilkeson GS; Quigg RJ
    Eur J Immunol; 2007 Jun; 37(6):1691-701. PubMed ID: 17523212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells.
    Qing X; Zavadil J; Crosby MB; Hogarth MP; Hahn BH; Mohan C; Gilkeson GS; Bottinger EP; Putterman C
    Arthritis Rheum; 2006 Jul; 54(7):2198-210. PubMed ID: 16804897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
    Wenderfer SE; Ke B; Hollmann TJ; Wetsel RA; Lan HY; Braun MC
    J Am Soc Nephrol; 2005 Dec; 16(12):3572-82. PubMed ID: 16207826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus.
    Foxley S; Zamora M; Hack B; Alexander RR; Roman B; Quigg RJ; Alexander JJ
    Brain Res; 2013 Apr; 1504():85-96. PubMed ID: 23410788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3aR inhibition reduces neurodegeneration in experimental lupus.
    Jacob A; Bao L; Brorson J; Quigg RJ; Alexander JJ
    Lupus; 2010 Jan; 19(1):73-82. PubMed ID: 19900981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis.
    Stahel PF; Frei K; Eugster HP; Fontana A; Hummel KM; Wetsel RA; Ames RS; Barnum SR
    J Immunol; 1997 Jul; 159(2):861-9. PubMed ID: 9218605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis.
    Alexander JJ; Bao L; Jacob A; Kraus DM; Holers VM; Quigg RJ
    Biochim Biophys Acta; 2003 Nov; 1639(3):169-76. PubMed ID: 14636948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis.
    Liu J; Tan Y; Zhang J; Zou L; Deng G; Xu X; Wang F; Ma Z; Zhang J; Zhao T; Liu Y; Li Y; Zhu B; Guo B
    J Hepatol; 2015 Feb; 62(2):354-62. PubMed ID: 25200905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
    Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
    J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
    Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
    Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRL/lpr lupus-prone mice show exaggerated ICAM-1-dependent leucocyte adhesion and transendothelial migration in response to TNF-alpha.
    Marshall D; Dangerfield JP; Bhatia VK; Larbi KY; Nourshargh S; Haskard DO
    Rheumatology (Oxford); 2003 Aug; 42(8):929-34. PubMed ID: 12730527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice.
    McHale JF; Harari OA; Marshall D; Haskard DO
    J Immunol; 1999 Oct; 163(7):3993-4000. PubMed ID: 10491002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
    Xu GL; Chen J; Yang F; Li GQ; Zheng LX; Wu YZ
    Hepatology; 2014 Jul; 60(1):114-24. PubMed ID: 24604562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis.
    Lalli PN; Strainic MG; Yang M; Lin F; Medof ME; Heeger PS
    Blood; 2008 Sep; 112(5):1759-66. PubMed ID: 18567839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta.
    Hernandez MX; Namiranian P; Nguyen E; Fonseca MI; Tenner AJ
    ASN Neuro; 2017 Feb; 9(1):1759091416687871. PubMed ID: 28078911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.